Adams Diversified Equity Fund’s ChemoCentryx, Inc. CCXI Stock Holding History

Adams Diversified Equity Fund’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-7,400	Closed	-$69K	–	210
2019 Q2	$69K	Sell	7,400 -8,300	-53%	-$96.1K	﹤0.01%	219
2019 Q1	$218K	Sell	15,700 -22,900	-59%	-$262K	0.01%	196
2018 Q4	$421K	Sell	38,600 -1,600	-4%	-$16.9K	0.03%	180
2018 Q3	$508K	Sell	40,200 -2,800	-7%	-$33.7K	0.03%	195
2018 Q2	$566K	Buy	+43,000	New	+$514K	0.03%	195
2017 Q4	–	Sell	-71,800	Closed	-$533K	–	220
2017 Q3	$533K	Sell	71,800 -2,600	-3%	-$21.6K	0.03%	210
2017 Q2	$696K	Sell	74,400 -13,500	-15%	-$99.1K	0.04%	192
2017 Q1	$640K	Buy	87,900 +2,400	+3%	+$17.3K	0.04%	205
2016 Q4	$633K	Buy	+85,500	New	+$616K	0.04%	203

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Adams Diversified Equity Fund's CCXI Position: Q3 2019 in Review

Adams Diversified Equity Fund sold out of ChemoCentryx, Inc. (CCXI) in Q3 2019, closing a stake of 7,400 shares — an estimated $69K sold.

Adams Diversified Equity Fund first reported a position in CCXI in Q4 2016 and held it in 9 quarters. The position peaked at $696K in Q2 2017. 100 funds tracked by Wall St. Rank hold CCXI as of Q3 2019.

Adams Diversified Equity Fund reported no remaining ChemoCentryx, Inc. position as of Q3 2019 after selling out during the quarter.
Adams Diversified Equity Fund sold 7,400 ChemoCentryx, Inc. shares in Q3 2019, an estimated $69K.
Adams Diversified Equity Fund first reported a position in ChemoCentryx, Inc. in Q4 2016 and held it in 9 quarters.
Adams Diversified Equity Fund's ChemoCentryx, Inc. position peaked at $696K in Q2 2017.
100 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2019.

Based on Adams Diversified Equity Fund's 13F filing for Q3 2019, filed 28 Oct 2019.